English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/217211
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Toward nanotechnology-enabled approaches against the COVID-19 pandemic

AuthorsWeiss, Carsten; Carriere, Marie; Fusco, Laura; Capua, Ilaria; Regla-Nava, José Ángel ; Pasquali, Matteo; Scott, James A.; Vitale, Flavia; Unal, Mehmet Altay; Mattevi, Cecilia; Bedognetti, Davide; Merkoçi, Arben ; Tasciotti, Ennio; Yilmazer, Açelya; Gogotsi, Yury; Stellacci, Francesco; Delogu, Lucia Gemma
KeywordsNanomaterials
Immunology
Infectious diseases
Viruses
Vaccination
Issue Date10-Jun-2020
PublisherACS Publications
CitationACS Nano 14(6): 6383-6406 (2020)
AbstractThe COVID-19 outbreak has fueled a global demand for effective diagnosis and treatment as well as mitigation of the spread of infection, all through large-scale approaches such as specific alternative antiviral methods and classical disinfection protocols. Based on an abundance of engineered materials identifiable by their useful physicochemical properties through versatile chemical functionalization, nanotechnology offers a number of approaches to cope with this emergency. Here, through a multidisciplinary Perspective encompassing diverse fields such as virology, biology, medicine, engineering, chemistry, materials science, and computational science, we outline how nanotechnology-based strategies can support the fight against COVID-19, as well as infectious diseases in general, including future pandemics. Considering what we know so far about the life cycle of the virus, we envision key steps where nanotechnology could counter the disease. First, nanoparticles (NPs) can offer alternative methods to classical disinfection protocols used in healthcare settings, thanks to their intrinsic antipathogenic properties and/or their ability to inactivate viruses, bacteria, fungi, or yeasts either photothermally or via photocatalysis-induced reactive oxygen species (ROS) generation. Nanotechnology tools to inactivate SARS-CoV-2 in patients could also be explored. In this case, nanomaterials could be used to deliver drugs to the pulmonary system to inhibit interaction between angiotensin-converting enzyme 2 (ACE2) receptors and viral S protein. Moreover, the concept of “nanoimmunity by design” can help us to design materials for immune modulation, either stimulating or suppressing the immune response, which would find applications in the context of vaccine development for SARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has important roles in diagnostics, with potential to support the development of simple, fast, and cost-effective nanotechnology-based assays to monitor the presence of SARS-CoV-2 and related biomarkers. In summary, nanotechnology is critical in counteracting COVID-19 and will be vital when preparing for future pandemics.
Publisher version (URL)https://doi.org/10.1021/acsnano.0c03697
URIhttp://hdl.handle.net/10261/217211
DOIhttp://dx.doi.org/10.1021/acsnano.0c03697
ISSN1936-0851
E-ISSN1936-086X
Appears in Collections:(CNB) Artículos
(CIN2) Artículos
(VICYT) Colección Especial COVID-19
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.